|
Market Closed -
Nasdaq
06:00:00 25/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 796.02 USD | -0.72% |
|
+0.83% | +3.13% |
| Market Cap | 79.49B 69.92B 65.91B 60.13B 112B 7,630B 113B 791B 306B 3,883B 298B 292B 12,637B | P/E 2026 * |
18.1x | P/E 2027 * | 15.7x |
|---|---|---|---|---|---|
| Enterprise Value | 72.31B 63.61B 59.96B 54.71B 102B 6,942B 103B 720B 279B 3,533B 272B 266B 11,497B | EV / Sales 2026 * |
4.26x | EV / Sales 2027 * | 3.75x |
| Free-Float |
71.06% | Yield 2026 * |
0.49% | Yield 2027 * | 0.55% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.72% | ||
| 1 week | +0.83% | ||
| Current month | -0.38% | ||
| 1 month | -3.92% | ||
| 3 months | +27.68% | ||
| 6 months | +7.33% | ||
| Current year | +3.13% |
| 1 week | 779.96 |  | 813.53 |
| 1 month | 769.57 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +0.83% | +37.96% | -3.49% | 80.07B | |
| +6.98% | +23.25% | +652.78% | +94.84% | 72.7B | |
| -0.80% | +1.19% | -10.26% | -29.77% | 60.45B | |
| -1.80% | -2.15% | -15.06% | +26.38% | 46.24B | |
| +0.14% | +1.58% | +3.62% | +158.04% | 45.97B | |
| -0.51% | +3.34% | +64.42% | -12.15% | 33.62B | |
| -0.16% | -2.49% | +47.86% | +114.18% | 25.26B | |
| -1.10% | +2.17% | +3.84% | +153.08% | 22.95B | |
| -0.82% | -2.20% | +57.40% | +98.36% | 15.44B | |
| +0.87% | -1.53% | +30.86% | +143.05% | 12.85B | |
| Average | -0.67% | +3.33% | +87.34% | +74.25% | 41.55B | |
| Weighted average by Cap. | -0.86% | +5.12% | +130.18% | +54.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.98B 14.93B 14.08B 12.84B 24.02B 1,630B 24.2B 169B 65.46B 829B 63.74B 62.35B 2,699B | 18.54B 16.3B 15.37B 14.02B 26.22B 1,779B 26.43B 184B 71.47B 906B 69.6B 68.08B 2,947B |
| Net income | 4.84B 4.26B 4.01B 3.66B 6.84B 464B 6.9B 48.14B 18.65B 236B 18.16B 17.77B 769B | 5.44B 4.79B 4.51B 4.12B 7.7B 522B 7.76B 54.14B 20.98B 266B 20.43B 19.99B 865B |
| Net Debt | -7.17B -6.31B -5.95B -5.43B -10.15B -688B -10.23B -71.36B -27.65B -350B -26.93B -26.34B -1,140B | -10.05B -8.84B -8.34B -7.61B -14.23B -965B -14.34B -100B -38.77B -491B -37.75B -36.93B -1,599B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | USD 796.02 | -0.72% | 602,564 |
| 23/09/26 | USD 801.82 | -0.26% | 721,110 |
| 22/09/26 | USD 803.90 | +0.72% | 600,266 |
| 21/09/26 | USD 798.17 | +1.70% | 704,526 |
| 18/09/26 | USD 784.85 | -0.58% | 2,473,436 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
